CNMD CONMED Corporation

44.23USD-0.56%Mkt Cap: 1.32B $P/E: 23.91

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot A…

Key Statistics

Company
Market Cap1.32B USD
Enterprise Value2.13B USD
Revenue (TTM)1.37B USD
Gross Profit750.48M USD
Net Income (TTM)47.05M USD
Revenue/Share44.70 USD
Last Price44.23 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.9K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)23.91
P/E (Forward)9.30
PEG1.84
EV/EBITDA9.36
EV/Revenue1.55
P/S0.97
P/B1.28
EPS (TTM)1.85
EPS (Forward)4.78
52W Range
31.4458% of range53.66
52W High53.66 USD
52W Low31.44 USD
Profitability
Gross Margin54.59%
Oper. Margin14.64%
EBITDA Margin16.58%
Profit Margin3.42%
ROE4.55%
ROA2.02%
Growth
Revenue Growth0.30%
Earnings Growth11.20%
Cash Flow & Leverage
Operating CF170.69M USD
CapEx (TTM)19.81M USD
FCF Margin9.58%
FCF Yield9.92%
Net Debt796.92M USD
Net Debt/EBITDA3.50
Balance Sheet
Debt/Equity0.81
Current Ratio1.48
Quick Ratio0.61
Book Value/Sh34.73 USD
Cash/Share1.25 USD
Dividends
Fwd Div Rate0.80 USD
Trail. Div Rate0.20 USD
Div. Yield0.00%
5Y Avg Yield0.88%
Payout Ratio10.81%
Ex-Div DateSep 15, 2025
Pay DateOct 3, 2025
Splits
Last Split3:2
Split DateSep 10, 2001
Analyst Consensus
Rating—
Target (Mean)45.50 USD
Upside (mean)+2.9%
Target Range43.00 USD – 49.00 USD
43.00+2.9% to mean49.00
# Analysts6
Ownership
Shares Out.29.95M
Float29.66M
Insiders0.43%
Institutions116.67%
Short Interest
Short Ratio7.0d
Short % Float8.48%
Short % Out.7.14%
Shares Short2.14M
Short (prev mo.)2.32M
Technical
SMA 5048.03 (-7.9%)
SMA 20040.97 (+8.0%)
Beta0.94
S&P 52W Chg16.45%
Avg Vol (30d)326.52K
Avg Vol (10d)319.38K
Technical Indicators
RSI (14)39.0
MACD-0.5345
MACD Signal-0.4156
MACD Hist.-0.1188
BB Upper47.65 USD
BB Middle45.97 USD
BB Lower44.28 USD
BB Width7.34%
ATR (14)1.558 USD
Vol Ratio (20d)1.52x